Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
Age
20–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant has a diagnosis of essential hypertension.
Participant is not treated with antihypertensive medication and meets protocol-specified blood pressure criteria.
Participant is treated with single antihypertensive medication, and meets protocol-specified blood pressure criteria.
Participant is being treated with up to dual oral antihypertensive medications, and will be able to discontinue the prior antihypertensive medication.
Participant has no clinically meaningful findings to be disqualified from the study at the discretion of the investigator.
You may not be if
Regarding hypertension, participant is currently taking \> 2 antihypertensive medications.
Participant has a history of significant multiple and/or severe allergies to ingredients of Nu-lotan or Preminent and thiazide drug or related drug (i.e., sulfonamide-containing "chlortalidone" medicines)
Participant is, at the time of signing informed consent, a user of recreational or illicit drugs or a recent history within the last year of drug or alcohol abuse or dependence.
Participant is pregnant or breastfeeding or expecting to conceive or has a positive pregnancy test at the screening visit.
Participant is currently participating or has participated in a study with an investigational compound (except losartan at any doses) or device within 30 days of signing informed consent.
